Efficacy of albumin in critically ill patients.
作者信息
Finfer Simon, Bellomo Rinaldo, Myburgh John, Norton Robyn
出版信息
BMJ. 2003 Mar 15;326(7389):559-60. doi: 10.1136/bmj.326.7389.559.
Abstract
摘要
相似文献
1
Efficacy of albumin in critically ill patients.白蛋白对重症患者的疗效。
BMJ. 2003 Mar 15;326(7389):559-60. doi: 10.1136/bmj.326.7389.559.
2
Colloid use for fluid resuscitation: evidence and spin.胶体用于液体复苏：证据与误导信息
Ann Intern Med. 2001 Aug 7;135(3):205-8. doi: 10.7326/0003-4819-135-3-200108070-00013.
3
[Use and misuse of albumin].[白蛋白的使用与误用]
Tidsskr Nor Laegeforen. 2005 Dec 15;125(24):3430-2.
4
Summaries for patients. Whether albumin therapy improves or worsens survival of critically ill patients is not known.患者摘要。白蛋白治疗对危重症患者的生存是改善还是恶化尚不清楚。
Ann Intern Med. 2001 Aug 7;135(3):S-25. doi: 10.7326/0003-4819-135-3-200108070-00003.
5
Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: a meta-analysis.使用明胶溶液作为围手术期和危重症患者血浆扩容剂的益处与风险：一项荟萃分析。
Anaesth Intensive Care. 2012 Jan;40(1):17-32. doi: 10.1177/0310057X1204000104.
6
7
[Albumin or physiologic saline to hypovolemic intensive care patients?].[白蛋白还是生理盐水用于低血容量重症监护患者？]
Ugeskr Laeger. 2004 Oct 18;166(43):3835.
8
Type of fluid in severe sepsis and septic shock.严重脓毒症和脓毒性休克中的液体类型。
Minerva Anestesiol. 2011 Dec;77(12):1190-6. Epub 2011 Jul 3.
9
[Excess mortality in critically ill patients after treatment with human albumin].[人血白蛋白治疗后重症患者的超额死亡率]
Ned Tijdschr Geneeskd. 1998 Aug 15;142(33):1855-8.
10
Do colloids in comparison to crystalloids for fluid resuscitation improve mortality?与晶体液相比，胶体液用于液体复苏是否能改善死亡率？
Trans R Soc Trop Med Hyg. 2010 May;104(5):311-2. doi: 10.1016/j.trstmh.2010.02.001. Epub 2010 Mar 5.
引用本文的文献
1
The Influence of Albumin Level in Critically Ill Children to Length of Stay and Mortality in Paediatric Intensive Care Unit.危重症患儿白蛋白水平对儿科重症监护病房住院时间和死亡率的影响
Open Access Maced J Med Sci. 2019 Oct 14;7(20):3455-3458. doi: 10.3889/oamjms.2019.445. eCollection 2019 Oct 30.
2
Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle.重症患者肠外营养与肠内营养的比较：一项采用意向性治疗原则的试验的荟萃分析。
Intensive Care Med. 2005 Jan;31(1):12-23. doi: 10.1007/s00134-004-2511-2. Epub 2004 Dec 9.
本文引用的文献
1
Human albumin solution for resuscitation and volume expansion in critically ill patients.用于危重症患者复苏和容量扩充的人血白蛋白溶液。
Cochrane Database Syst Rev. 2002(1):CD001208. doi: 10.1002/14651858.CD001208.
2
Summaries for patients. Whether albumin therapy improves or worsens survival of critically ill patients is not known.患者摘要。白蛋白治疗对危重症患者的生存是改善还是恶化尚不清楚。
Ann Intern Med. 2001 Aug 7;135(3):S-25. doi: 10.7326/0003-4819-135-3-200108070-00003.
3
Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.输注人白蛋白后的患者生存率。一项随机对照试验的荟萃分析。
Ann Intern Med. 2001 Aug 7;135(3):149-64. doi: 10.7326/0003-4819-135-3-200108070-00007.
4
Human albumin administration in critically ill patients. Some patients may benefit.在危重症患者中输注人白蛋白。部分患者可能获益。
BMJ. 1998 Sep 26;317(7162):885-6.
5
6
Albumin: don't confuse us with the facts. Rather than fulminating, seek to answer the questions raised.白蛋白：别用事实来误导我们。与其大发雷霆，不如试着回答提出的问题。
BMJ. 1998 Sep 26;317(7162):829-30. doi: 10.1136/bmj.317.7162.829.
7
Action on human albumin not swift enough.对人白蛋白的作用不够迅速。
BMJ. 1998 Aug 8;317(7155):367. doi: 10.1136/bmj.317.7155.367.
8
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.危重症患者使用人白蛋白：随机对照试验的系统评价
BMJ. 1998 Jul 25;317(7153):235-40. doi: 10.1136/bmj.317.7153.235.
9
Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful.危重症患者输注人白蛋白后的超额死亡率。临床和病理生理学证据表明白蛋白有害。
BMJ. 1998 Jul 25;317(7153):223-4. doi: 10.1136/bmj.317.7153.223.
Zotero 插件